vs
Side-by-side financial comparison of Evolus, Inc. (EOLS) and James River Group Holdings, Inc. (JRVR). Click either name above to swap in a different company.
James River Group Holdings, Inc. is the larger business by last-quarter revenue ($151.4M vs $73.1M, roughly 2.1× Evolus, Inc.). On growth, Evolus, Inc. posted the faster year-over-year revenue change (6.7% vs -12.1%). Over the past eight quarters, Evolus, Inc.'s revenue compounded faster (4.6% CAGR vs -10.3%).
Evolus, Inc. is a medical aesthetics company focused on developing and commercializing non-surgical cosmetic treatment solutions. Its flagship product is a prescription neuromodulator designed to reduce moderate to severe glabellar frown lines, serving licensed aesthetic healthcare providers and consumers across North America, Europe, and key Asia-Pacific regional markets.
James River Corporation was an American pulp and paper company based in Richmond, Virginia, once the largest paper manufacturer in the world.
EOLS vs JRVR — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $73.1M | $151.4M |
| Net Profit | $-10.7M | — |
| Gross Margin | 66.9% | — |
| Operating Margin | 23.8% | — |
| Net Margin | -14.6% | — |
| Revenue YoY | 6.7% | -12.1% |
| Net Profit YoY | — | — |
| EPS (diluted) | $-0.16 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $73.1M | $151.4M | ||
| Q4 25 | $90.3M | $167.7M | ||
| Q3 25 | $69.0M | $172.7M | ||
| Q2 25 | $69.4M | $174.8M | ||
| Q1 25 | $68.5M | $172.3M | ||
| Q4 24 | $78.9M | $126.7M | ||
| Q3 24 | $61.1M | $191.5M | ||
| Q2 24 | $66.9M | $188.3M |
| Q1 26 | $-10.7M | — | ||
| Q4 25 | $130.0K | $32.1M | ||
| Q3 25 | $-15.7M | $1.0M | ||
| Q2 25 | $-17.1M | $4.8M | ||
| Q1 25 | $-18.9M | $9.6M | ||
| Q4 24 | $-6.8M | $-64.8M | ||
| Q3 24 | $-19.2M | $-39.4M | ||
| Q2 24 | $-11.3M | $7.6M |
| Q1 26 | 66.9% | — | ||
| Q4 25 | 65.7% | — | ||
| Q3 25 | 66.5% | — | ||
| Q2 25 | 65.3% | — | ||
| Q1 25 | 68.1% | — | ||
| Q4 24 | 66.7% | — | ||
| Q3 24 | 68.9% | — | ||
| Q2 24 | 70.3% | — |
| Q1 26 | 23.8% | — | ||
| Q4 25 | 4.7% | 14.6% | ||
| Q3 25 | -16.7% | 1.5% | ||
| Q2 25 | -14.7% | 4.2% | ||
| Q1 25 | -22.1% | 9.3% | ||
| Q4 24 | -2.9% | -57.0% | ||
| Q3 24 | -25.3% | -27.1% | ||
| Q2 24 | -11.5% | 10.7% |
| Q1 26 | -14.6% | — | ||
| Q4 25 | 0.1% | 19.1% | ||
| Q3 25 | -22.8% | 0.6% | ||
| Q2 25 | -24.7% | 2.7% | ||
| Q1 25 | -27.6% | 5.6% | ||
| Q4 24 | -8.6% | -51.1% | ||
| Q3 24 | -31.4% | -20.6% | ||
| Q2 24 | -17.0% | 4.0% |
| Q1 26 | $-0.16 | — | ||
| Q4 25 | $0.01 | $0.59 | ||
| Q3 25 | $-0.24 | $-0.02 | ||
| Q2 25 | $-0.27 | $0.06 | ||
| Q1 25 | $-0.30 | $0.16 | ||
| Q4 24 | $-0.11 | $-2.44 | ||
| Q3 24 | $-0.30 | $-1.10 | ||
| Q2 24 | $-0.18 | $0.13 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $49.8M | $228.2M |
| Total DebtLower is stronger | $156.4M | — |
| Stockholders' EquityBook value | — | $518.4M |
| Total Assets | $220.6M | $4.8B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $49.8M | $228.2M | ||
| Q4 25 | $53.8M | $260.9M | ||
| Q3 25 | $43.5M | $238.8M | ||
| Q2 25 | $61.7M | $220.0M | ||
| Q1 25 | $67.9M | $279.4M | ||
| Q4 24 | $87.0M | $362.3M | ||
| Q3 24 | $85.0M | $359.8M | ||
| Q2 24 | $93.7M | $672.5M |
| Q1 26 | $156.4M | — | ||
| Q4 25 | $146.1M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $121.8M | — | ||
| Q4 24 | $121.5M | — | ||
| Q3 24 | $121.2M | — | ||
| Q2 24 | $120.9M | — |
| Q1 26 | — | $518.4M | ||
| Q4 25 | $-23.1M | $538.2M | ||
| Q3 25 | $-28.8M | $503.6M | ||
| Q2 25 | $-18.7M | $492.6M | ||
| Q1 25 | $-6.6M | $484.5M | ||
| Q4 24 | $5.5M | $460.9M | ||
| Q3 24 | $5.9M | $530.3M | ||
| Q2 24 | $19.3M | $541.8M |
| Q1 26 | $220.6M | $4.8B | ||
| Q4 25 | $225.9M | $4.9B | ||
| Q3 25 | $219.0M | $5.0B | ||
| Q2 25 | $228.8M | $5.0B | ||
| Q1 25 | $213.4M | $4.9B | ||
| Q4 24 | $232.6M | $5.0B | ||
| Q3 24 | $229.6M | $5.0B | ||
| Q2 24 | $233.8M | $4.7B |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 22.00× | — | ||
| Q3 24 | 20.58× | — | ||
| Q2 24 | 6.26× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EOLS
| Product revenue, net | $72.7M | 99% |
| Service revenue | $390.0K | 1% |
JRVR
Segment breakdown not available.
